Entrez Id: |
158506 |
Gene Symbol: |
CBLL2 |
CBLL2
|
Q8N7E2
|
Cbl proto-oncogene like 2
|
Enzyme
|
235
|
0.476 |
0.808 |
|
0.100 |
None
|
1.000 |
54
|
0
|
2002 |
2019 |
Entrez Id: |
100359403 |
Gene Symbol: |
PARK16 |
PARK16
|
|
Parkinson disease 16 (susceptibility)
|
|
5
|
0.861 |
0.077 |
|
0.400 |
None
|
0.963 |
27
|
0
|
2009 |
2019 |
Entrez Id: |
2630 |
Gene Symbol: |
GBAP1 |
GBAP1
|
|
glucosylceramidase beta pseudogene 1
|
|
64
|
0.623 |
0.538 |
|
0.100 |
None
|
1.000 |
26
|
1
|
2005 |
2019 |
LOC107987479
|
|
cytochrome P450 2D6
|
|
76
|
0.597 |
0.769 |
|
0.100 |
None
|
0.917 |
12
|
0
|
1994 |
2017 |
Entrez Id: |
170534 |
Gene Symbol: |
PARK10 |
PARK10
|
|
Parkinson disease 10 (susceptibility)
|
|
3
|
0.890 |
0.038 |
|
0.100 |
None
|
0.917 |
12
|
0
|
2005 |
2020 |
Entrez Id: |
4747 |
Gene Symbol: |
NEFL |
NEFL
|
P07196
|
neurofilament light
|
|
247
|
0.488 |
0.769 |
|
0.100 |
None
|
1.000 |
12
|
0
|
2002 |
2019 |
Entrez Id: |
5072 |
Gene Symbol: |
PARK3 |
PARK3
|
|
Parkinson disease 3 (autosomal dominant, Lewy body)
|
|
6
|
0.821 |
0.038 |
|
0.100 |
None
|
0.917 |
12
|
0
|
1999 |
2013 |
Entrez Id: |
442890 |
Gene Symbol: |
MIR133B |
MIR133B
|
|
microRNA 133b
|
|
109
|
0.555 |
0.808 |
|
0.090 |
None
|
0.889 |
9
|
0
|
2007 |
2019 |
LINC02210-CRHR1
|
P34998
|
LINC02210-CRHR1 readthrough
|
|
123
|
0.570 |
0.692 |
|
0.100 |
None
|
1.000 |
8
|
32
|
2009 |
2016 |
LINC02210
|
|
long intergenic non-protein coding RNA 2210
|
|
10
|
0.861 |
0.154 |
|
0.100 |
None
|
1.000 |
8
|
6
|
2009 |
2016 |
LINC01672
|
|
long intergenic non-protein coding RNA 1672
|
|
268
|
0.462 |
0.846 |
|
0.070 |
None
|
1.000 |
7
|
0
|
2006 |
2019 |
Entrez Id: |
246744 |
Gene Symbol: |
STH |
STH
|
Q8IWL8
|
saitohin
|
|
27
|
0.705 |
0.385 |
|
0.160 |
None
|
1.000 |
7
|
3
|
2003 |
2015 |
Entrez Id: |
100128977 |
Gene Symbol: |
MAPT-AS1 |
MAPT-AS1
|
|
MAPT antisense RNA 1
|
|
34
|
0.711 |
0.269 |
|
0.120 |
None
|
1.000 |
6
|
32
|
2009 |
2019 |
Entrez Id: |
407006 |
Gene Symbol: |
MIR221 |
MIR221
|
|
microRNA 221
|
|
304
|
0.449 |
0.846 |
|
0.050 |
None
|
0.800 |
5
|
0
|
2013 |
2020 |
Entrez Id: |
407041 |
Gene Symbol: |
MIR34B |
MIR34B
|
|
microRNA 34b
|
|
165
|
0.509 |
0.808 |
|
0.050 |
None
|
1.000 |
5
|
0
|
2011 |
2017 |
Entrez Id: |
440915 |
Gene Symbol: |
POTEKP |
POTEKP
|
Q9BYX7
|
POTE ankyrin domain family member K, pseudogene
|
|
131
|
0.542 |
0.769 |
|
0.050 |
None
|
1.000 |
5
|
0
|
1997 |
2002 |
Entrez Id: |
4513 |
Gene Symbol: |
COX2 |
COX2
|
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
875
|
0.352 |
0.962 |
|
0.050 |
None
|
0.800 |
5
|
0
|
2000 |
2018 |
Entrez Id: |
574034 |
Gene Symbol: |
MIR433 |
MIR433
|
|
microRNA 433
|
|
69
|
0.604 |
0.538 |
|
0.050 |
None
|
0.800 |
5
|
0
|
2008 |
2018 |
Entrez Id: |
80316 |
Gene Symbol: |
PPP1R2C |
PPP1R2C
|
O14990
|
PPP1R2C family member C
|
Enzyme modulator
|
231
|
0.478 |
0.846 |
|
0.050 |
None
|
1.000 |
5
|
0
|
2005 |
2019 |
CCNT2-AS1
|
|
CCNT2 antisense RNA 1
|
|
12
|
0.931 |
0.115 |
|
0.100 |
None
|
1.000 |
4
|
2
|
2011 |
2017 |
Entrez Id: |
100616119 |
Gene Symbol: |
MIR4697 |
MIR4697
|
|
microRNA 4697
|
|
2
|
0.931 |
0.077 |
|
0.040 |
None
|
1.000 |
4
|
0
|
2016 |
2018 |
Entrez Id: |
107984474 |
Gene Symbol: |
LRRK2-DT |
LRRK2-DT
|
|
LRRK2 divergent transcript
|
|
6
|
0.861 |
0.154 |
|
0.100 |
None
|
1.000 |
4
|
6
|
2012 |
2017 |
Entrez Id: |
1564 |
Gene Symbol: |
CYP2D7 |
CYP2D7
|
A0A087X1C5
|
cytochrome P450 family 2 subfamily D member 7 (gene/pseudogene)
|
|
42
|
0.659 |
0.577 |
|
0.040 |
None
|
0.750 |
4
|
0
|
1998 |
2016 |
DNAJB1P1
|
|
DnaJ heat shock protein family (Hsp40) member B1 pseudogene 1
|
|
51
|
0.650 |
0.654 |
|
0.040 |
None
|
1.000 |
4
|
0
|
2009 |
2018 |
Entrez Id: |
192142 |
Gene Symbol: |
RLS1 |
RLS1
|
|
Restless legs syndrome, susceptibility to
|
|
37
|
0.705 |
0.423 |
|
0.040 |
None
|
0.750 |
4
|
0
|
2015 |
2019 |